Clinical Trials in Massachusetts

Showing 1901-1920 of 8,511 trials

Clinical Study to Evaluate the Safety and Efficacy of Candela Technology

NCT06202274

This is a non-randomized, multi-center, open-label, prospective clinical study evaluating the clinical treatment with Candela Medical Technology.

Hair ReductionTattoo RemovalWrinkle+4 more

Candela Corporation500 participantsStarted Oct 2023

Jacksonville, Florida, United States • Marlborough, Massachusetts, United States • Yokneam Illit, Israel

Active Not RecruitingNA8.1 miles

Clinical Study Evaluating Nordlys™ SWT IPL for Dry Eye Disease (DED) Due to MGD

NCT06064071

Clinical Study Evaluating Nordlys™ System with Selective Waveband Technology (SWT)® Intense Pulsed Light (IPL) Applicators for Dry Eye Disease (DED) due to Meibomian Gland Dysfunction (MGD).

Meibomian Gland DysfunctionDry Eye Disease

Candela Corporation100 participantsStarted Sep 2023

Miami, Florida, United States • Marlborough, Massachusetts, United States • Buenos Aires, Argentina

COMPLETEDPhase 314 miles

Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2)

NCT04057573

The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in adolescent and adult participants with non-segmental vitiligo for whom total body involved vitiligo area (facial and nonfacial) does not exceed 10% body surface area (BSA).

Non-segmental Vitiligo

Incyte Corporation344 participantsStarted Oct 2019

Gilbert, Arizona, United States • Fremont, California, United States • Irvine, California, United States +73 more locations

Clinical Study to Evaluate the Safety and Efficacy of Candela Technology

Clinical Study Evaluating Nordlys™ SWT IPL for Dry Eye Disease (DED) Due to MGD

Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2)

Find Trials by Condition in Massachusetts

Families Left Behind

Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

ERG Components in Schizophrenia and Bipolar Disorder Type I

Efficacy & Safety Study of Bilateral IVT Injection of GS010 in LHON Subjects Due to the ND4 Mutation for up to 1 Year

Safety and Efficacy Study of Inhaled Carbon Monoxide to Treat Acute Respiratory Distress Syndrome (ARDS)

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Study of JK07 in Patients With Chronic Heart Failure

The Effects of a Low Glycemic Load Diet on Dysglycemia and Body Composition in Adults With Cystic Fibrosis-Related Diabetes

Study of Uterine Prolapse Procedures - Randomized Trial

Mindfulness, Optimism, and Resilience for Perinatal Health and Equity Study

The Rhode Island Prescription and Illicit Drug Study

Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1)

A Phase 2 Safety and Efficacy Study of INCB050465 in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (CITADEL-202)

A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7248824 in Participants With Angelman Syndrome (AS)

A Study of JNJ-64264681 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis

A Proof-of-concept Study of the Efficacy and Safety of Nipocalimab in Participants With Active Rheumatoid Arthritis